Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing burden of lifestyle-related diseases and the growing geriatric population
3.2.1.2 Increasing funding initiatives and government program
3.2.1.3 Increasing demand precision medicine
3.2.1.4 Long regulatory pathways and high development costs
3.2.2 Industry pitfalls & challenges
3.2.2.1 Ethical and safety concern
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Human Microbiome Market, By Site, 2018 - 2032 (USD Million)
5.1 Key trends
5.2 Digestive tract
5.3 Lung
5.4 Reproductive cavity
5.5 Skin
5.6 Other sites
Chapter 6 Human Microbiome Market, By Application, 2018 – 2032 (USD Million)
6.1 Key trends
6.2 Therapeutics
6.3 Diagnostics
Chapter 7 Human Microbiome Market, By Disease, 2018 – 2032 (USD Million)
7.1 Key trends
7.2 Infectious diseases
7.3 Gastrointestinal diseases
7.4 Endocrine & metabolic diseases
7.5 Cancer
7.6 Central nervous system disorder
7.7 Other diseases
Chapter 8 Human Microbiome Market, By Product, 2018 – 2032 (USD Million)
8.1 Key trends
8.2 Drugs
8.3 Probiotics
8.4 Prebiotics
8.5 Diagnostic tests
8.6 Other products
Chapter 9 Human Microbiome Market, By Region, 2018 – 2032 (USD Million)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
Chapter 10 Company Profiles
10.1 Seres Therapeutics
10.2 Enterome
10.3 Second Genome Inc.
10.4 DuPont
10.5 Synthetic Biologics, Inc.
10.6 Synlogic
10.7 Vedanta Biosciences, Inc.
10.8 Metabiomics Corporation
10.9 MICROBIOME THERAPEUTICS LLC
10.10 4D pharma plc
